Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study

Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study

Abstract. Introduction:. Fibromyalgia (FM) is a chronic fluctuating, nociplastic pain condition. Naltrexone is a µ-opioid-receptor antagonist; preliminary studies have indicated a pain-relieving effect of low-dose naltrexone (LDN) in patients with FM. The impetus for studying LDN is the assumption o...

Full description

Bibliographic Details
Main Authors: Kirsten Bested, Lotte M. Jensen, Trine Andresen, Grete Tarp, Louise Skovbjerg, Torben S.D. Johansen, Anne V. Schmedes, Ida K. Storgaard, Jonna S. Madsen, Mads U. Werner, Anette Bendiksen
Format: Article
Language:English
Published: Wolters Kluwer 2023-08-01
Series:PAIN Reports
Online Access:http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000001080

Internet

http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000001080

Similar Items